Role of senescence and mitotic catastrophe in cancer therapy

Cell Division

Volumn 5, Issue , 2010, Pages

  Singh, Richa ^a   George, Jasmine ^a   Shukla, Yogeshwer ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77249143499     PISSN: None     EISSN: 17471028     Source Type: Journal    
DOI: 10.1186/1747-1028-5-4     Document Type: Review

References (109)

1. Jemal A, Seigel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics. CA Cancer J Clin 2006, 56:106-130. 10.3322/canjclin.56.2.106, 16514137.
2. Hanahan D, Weinberg RA. The hallmark of cancer. Cell 2000, 100:57-70. 10.1016/S0092-8674(00)81683-9, 10647931.
3. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003, 426:194-198. 10.1038/nature02118, 14608368.
4. Bucher N, Britten CD. G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer. Br J Cancer 2008, 98:523-528. 10.1038/sj.bjc.6604208, 2243162, 18231106.
5. Verheij M. Clinical biomarkers and imaging for radiotherapy-induced cell death. Cancer Metastasis Rev 2008, 3:471-480.
6. Robinson BI. Tumor Cell Senescence in Cancer Treatment. Cancer Res 2003, 63:2705-2715.
7. Dimri GP. What has senescence got to do with cancer?. Cancer Cell 2005, 7:505-512. 10.1016/j.ccr.2005.05.025, 1769521, 15950900.
8. Stepieñ A, Izdebska M, Grzanka A. The types of cell death. Postepy Hig Med Dosw 2007, 61:420-428.
9. Narita M, Lowe SW. Senescence comes of age. Nat Med 2005, 11:920-922. 10.1038/nm0905-920, 16145569.
10. McGlynn LM, Kirkegaard T, Edwards J, Tovey S, Cameron D, Twelves C, Bartlett JM, Cooke TG. Ras/Raf-1/MAPK pathway mediates response to tamoxifen but not chemotherapy in breast cancer patients. Clin Cancer Res 2009, 15:1487-1495. 10.1158/1078-0432.CCR-07-4967, 19228750.
11. Gewirtz DA, Holt SE, Elmore LW. Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation. Biochem Pharmacol 2008, 76:947-957. 10.1016/j.bcp.2008.06.024, 18657518.
12. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965, 37:614-636. 10.1016/0014-4827(65)90211-9, 14315085.
13. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961, 25:585-621.
14. Shay JW, Wright WE. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 2005, 5:867-874.
15. Baird DM. Mechanisms of telomeric instability. Cytogenet Genome Res 2009, 4:308-314.
16. Parkinson EK, Fitchett C, Cerese. Dissecting the non-canonical functions of telomerase. Cytogenet Genome Res 2009, 4:273-280.
17. Raynaud CM, Sabatier L, Philipot O, Olaussen KA, Soria JC. Telomere length, telomeric proteins and genomic instability during the multistep carcinogenic process. Crit Rev Oncol Hematol 2008, 2:99-117.
18. Cheung AL, Front DW. Telomere dysfunction, genome instability and cancer. Biosci 2008, 13:2075-2090.
19. Smogorzewska T de L. Different telomere damage signaling pathways in human and mouse cells. EMBO J 2002, 21:4338-4348. 10.1093/emboj/cdf433, 126171, 12169636.
20. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000, 406:641-645. 10.1038/35020592, 10949306.
21. Svenson U, Nordfjäll K, Stegmayr B, Manjer J, Nilsson P, Tavelin B, Henriksson R, Lenner P, ranRoos G. Breast Cancer Survival Is Associated with Telomere Length in Peripheral Blood Cells. Cancer Res 2008, 10:3618-3623.
22. Wu X, Amos CI, Zhu Y, Zhao H, Grossman BH, Shay JW, Luo S, Hong WK, Spitz MR. Telomere Dysfunction: A Potential Cancer Predisposition Factor. J Natl Cancer Inst 2003, 16:1211-1218.
23. Kurz DJ, Decary S, Hong Y, Erusalimsky ID. Senescence-associated β-galactosidase reflects an increase in lysosomal mass during replicative aging in human endothelial cells. J Cell Sci 2000, 113:3613-3622.
24. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O. A biomarker that defines senescent cell culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995, 92:9363-9367. 10.1073/pnas.92.20.9363, 40985, 7568133.
25. Trougakos IP, Gonos ES. Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases. Free Radic Res 2006, 40:1324-1334. 10.1080/10715760600902310, 17090421.
26. Feng Z, Hu W, Rajagopal G, Levine AJ. The tumor suppressor p53: cancer and aging. Cell Cycle 2008, 7:842-847.
27. Kaufmann AM, Backsch C, Schneider A, Dürst M, Gynakol Z. HPV induced cervical carcinogenesis: Molecular basis and vaccine development. Zentralbl Gynakol 2002, 11:511-524.
28. Mazurek A, Kuc P, Mazurek-Wadolkowska E, Laudanski T. A role of thymidine phosphorylase and P53 tissue protein expression in biology of endometrial cancer. Neoplasma 2008, 55:261-265.
29. den Reijer PM, Maier AB, Westendorp RG, van Heemst D. Influence of the TP53 codon 72 polymorphism on the cellular responses to X-irradiation in fibroblasts from nonagenarians. Mech Ageing Dev 2008, 4:175-182.
30. Fujita K, Mondal AM, Horikawa I, Nguyen GH, Kumamoto K, Sohn JJ, Bowman ED, Mathe EA, Schetter AJ, Pine SR, Ji H, Vojtesek B, Bourdon JC, Lane DP, Harris CC. p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence. Nat Cell Biol 2009, 9:1135-1142.
31. Brian DL, Adam MB, Matthew SP, William HC, James AM, David MT. Distinct roles for p107 and p130 in Rb-independent cellular senescence. Cell Cycle 2008, 7:1262-1268.
32. Natalija F, Pirkko H, Risto E. Effects of estradiol and medroxyprogesterone acetate on expression of the cell cycle proteins cyclin D1, p21 and p27 in cultured human breast tissues. Cell Cycle 2008, 7:71-80.
33. Olsson A, Norberg M, Okvist A, Derkow K, Choudhury A, Tobin G, Celsing F, Osterborg FA, Rosenquist R, Jondal M, Osorio LM. Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia. Br J Cancer 2007, 97:769-767. 10.1038/sj.bjc.6603951, 2360383, 17726463.
34. Lin HL, Chiou SH, Wu CW, Lin WB, Chen LH, Yang YP, Tsai ML, Uen YH, Liou JP, Chi CW. Combretastatin A4-Induced Differential Cytotoxicity and Reduced Metastatic Ability by Inhibition of AKT Function in Human Gastric Cancer Cells. J Pharmacol Exp Ther 2007, 323:365-373. 10.1124/jpet.107.124966, 17646428.
35. Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, Higashimoto Y, Appella E, Minucci S, Pandolfi PP, Pelicci PG. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 2000, 406:207-210. 10.1038/35021000, 10910364.
36. Ewald JA, Peters N, Desotelle JA, Hoffmann FM, Jarrard DF. A High-Throughput Method to Identify Novel Senescence-Inducing Compounds. J Biomol Screen 2009, 7:853-858.
37. Bazarov AV, Hines WC, Mukhopadhyay R, Beliveau A, Melodyev S, Zaslavsky Y, Yaswen P. Telomerase activation by c-Myc in human mammary epithelial cells requires additional genomic changes. Cell Cycle 2009, 20:3373-3378.
38. Xia Y, Ning Z, Wade TJ, Mumford JL. Elevated human telomerase reverse transcriptase gene expression in blood cells associated with chronic arsenic exposure in Inner Mongolia, China. Mo J Environ Health Perspect 2009, 117:354-360.
39. Dong X, Liu A, Zer C, Feng J, Zhen Z, Yang M, Zhong L. siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells. BMC Cancer 2009, 9:133. 10.1186/1471-2407-9-133, 2691745, 19416503.
40. Goldblatt EM, Gentry ER, Fox MJ, Gryaznov SM, Shen C, Herbert BS. The telomerase template antagonist GRN163L alters MDA-MB-231 breast cancer cell morphology, inhibits growth, and augments the effects of paclitaxel. Mol Cancer Ther 2009, 7:2027-2035.
41. Bartholomew JN, Volonte D, Galbiati F. Caveolin-1 regulates the antagonistic pleiotropic properties of cellular senescence through a novel Mdm2/p53-mediated pathway. Cancer Res 2009, 69:2878-2886. 10.1158/0008-5472.CAN-08-2857, 19318577.
42. Kasper Barth K. Bleomycin and its role in inducing apoptosis and senescence in lung cells - modulating effects of caveolin-1. Curr Cancer Drug Targets 2009, 3:341-353.
43. Kang JY, Kim JJ, Jang SY, Bae YS. The p53-p21Cip1/WAF1 pathway is necessary for cellular senescence induced by the inhibition of protein kinase CKII in human colon cancer cells. Mol Cells
44. Sliwinska MA, Mosieniak G, Wolanin K, Babik A, Piwocka K, Magalska A, Szczepanowska J, Fronk J, Sikora E. Induction of senescence with doxorubicin leads to increased genomic instability of HCT116 cells. Mech Ageing Dev 2009, 130:24-32. 10.1016/j.mad.2008.04.011, 18538372.
45. Widodo N, Shah N, Priyandoko D, Ishii T, Kaul SC, Wadhwa R. Deceleration of senescence in normal human fibroblasts by withanone extracted from ashwagandha leaves. J Gerontol A Biol Sci Med Sci 2009, 10:1031-1038.
46. Santarosa M, Col LD, Tonin E, Caragnano A, Viel A, Maestro R. Premature senescence is a major response to DNA cross-linking agents in BRCA1-defective cells: implication for tailored treatments of BRCA1 mutation carriers. Mol Cancer Ther 2009, 8:844. 10.1158/1535-7163.MCT-08-0951, 19372557.
47. Yu H, McDaid R, Lee J, Possik P, Li L, Kumar SM, Elder DE, Belle PV, Gimotty P, Guerra M, Hammond R, Nathanson KL, Palma MD, Herlyn M, Xu X. The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes. Am J Path 2009, 174:2367-2377. 10.2353/ajpath.2009.081057, 19389934.
48. Lau GI, Loo WT, Chow LW. Neoadjuvant chemotherapy for breast cancer determined by chemosensitivity assay achieves better tumor response. Biomed Pharmacother 2007, 9:562-565.
49. Liu J, Zhawar VK, Kaur G, Kaur GP, Deriel JK, Kandpal RP, Athwal RS. Chromosome 6 encoded RNaseT2 protein is a cell growth regulator. J Cell Mol Med 2009,
50. Lin J, Chen X, Deng L. Observation of replicative senescence of rat chondrocytes in vitro. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2007, 11:1228-1232.
51. Nah SS, Won HJ, Park HJ, Ha E, Chung JH, Cho HY, Baik HH. Melatonin inhibits human fibroblast-like synoviocyte proliferation via extracellular signal-regulated protein kinase/P21(CIP1)/P27(KIP1) pathways. J Pineal Res 2009, 1:70-74.
52. Wu YH, Cheng ML, Ho HY, Chiu DT, Wang TC. Telomerase prevents accelerated senescence in glucose-6-phosphate dehydrogenase (G6PD)-deficient human fibroblasts. J Biomed Sci 2009, 16:18. 10.1186/1423-0127-16-18, 2653519, 19272180.
53. Dey D, Saxena M, Paranjape AN, Krishnan V, Giraddi R, Kumar MV, Mukherjee G, Rangarajan A. Phenotypic and functional characterization of human mammary stem/progenitor cells in long term culture. PLoS One 2009, 4:e5329. 10.1371/journal.pone.0005329, 2669709, 19390630.
54. Wieringa B, Groof AJ, te Lindert MM, van Dommelen MM, Wu M, Willemse M, Smift AL, Winer M, Oerlemans F, Pluk H, Fransen JA. Increased OXPHOS activity precedes rise in glycolytic rate in H-RasV12/E1A transformed fibroblasts that develop a Warburg phenotype. Mol Cancer 2009, 8:54. 10.1186/1476-4598-8-54, 2734543, 19646236.
55. Valacchi G, Pecorelli A, Mencarelli M, Maioli E, Davis PA. Beta-carotene prevents ozone-induced proinflammatory markers in murine skin. Toxicol Ind Health 2009, (4-5):241-247. 10.1177/0748233709103030, 19651793.
56. Wakoh T, Uekawa N, Terauchi K, Sugimoto M, Ishigami A, Shimada J, Maruyama M. Implication of p53-dependent cellular senescence related gene, TARSH in tumor suppression. Biochem Biophys Res Commun 2009, 4:807-812.
57. Chesnokova V, Zonis S, Kovacs K, Shlomo AB, Wawrowsky K, Bannykh S, Melmed S. p21Cip1 restrains pituitary tumor growth. PNAS 2008, 105:17498-17503. 10.1073/pnas.0804810105, 2577704,2577704, 18981426.
58. Schindler EM, Hindes A, Gribben EL, Burns CJ, Yin Y, Lin MH, Owen RJ, Longmore GD, Kissling GE, Arthur JS, Efimova T. p38delta Mitogen-activated protein kinase is essential for skin tumor development in mice. Cancer Res 2009, 69:4648-4655. 10.1158/0008-5472.CAN-08-4455, 19458068.
59. Varna M, Lehmann CJ, Turpin E, Marangoni E, Bouchtaoui ME, Jeanne M, Grigoriu C, Ratajczak P, Leboeuf C, Plassa LF, Ferreira I, Poupon MF, Janin A, de The H Bertheau P. p53 dependent cell-cycle arrest triggered by chemotherapy in xenografted breast tumors. Int J Cancer 2008, 124:991-997.
60. Rajaraman R, Guernsey DL, Rajaraman MM, Rajaraman SR. Stem cells, senescence, neosis and self-renewal in cancer. Cancer Cell Int 2006, 6:25. 10.1186/1475-2867-6-25, 1664585, 17092342.
61. Rengaswami R, Rajaraman MM, Rajaraman SR, Guernsey DL. Neosis-a paradigm of self-renewal in cancer. Cell Biol Int 2005, 29:1084-1097. 10.1016/j.cellbi.2005.10.003, 16316756.
62. Sundaram M, Guernsey DL, Rajaraman MM, Rajaraman. Neosis: a novel type of cell division in cancer. R Cancer Biol Ther 2004, 2:207-218.
63. Solari F, Domenget C, Gire V, Woods C, Lazarides E, Rousset B, Jurdic P. Multinucleated cells can continuously generate mononcleated cells in the absence of mitosis: a study of the avian osteoclast lineage. J Cell Sci 1995, 108:3233-3241.
64. Erenpreisa J, Cragg MS. Cancer: a matter of life cycle?. Cell Biol Int 2007, 12:1507-1510.
65. Navolanic PM, Akula SM, McCubrey JA. Neosis and its potential role in cancer development and chemoresistance. Cancer Biol Ther 2004, 2:219-220.
66. Kennedy AR, Murphy G, Little JB. Effect of time and duration of exposure to 12-O-tetradeconoylphorbol-13-acetate on Xray transformation of C3H10T1/2 cells. Cancer Res 1980, 40:1915-1920.
67. Nigg EA. Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol 2001, 2:21-32. 10.1038/35048096, 11413462.
68. Vakifahmetoglu H, Olsson M, Zhivotovsky B. Death through a tragedy: mitotic catastrophe. Cell Death Differ 2008, 15:1153-1162. 10.1038/cdd.2008.47, 18404154.
69. Li JJ, Li SA. Mitotic kinases: The key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis. Pharmacol Ther 2006, 111:974-984. 10.1016/j.pharmthera.2006.02.006, 16603252.
70. Castedo M, Perfettini JL, Roumier T, Valent A, Raslova H, Yakushijin K, Horne D, Feunteun J, Lenoir G, Medema R, Vainchenker W, Kroemer G. Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy. Oncogene 2004, 23:4362-4370. 10.1038/sj.onc.1207572, 15048075.
71. Roninson IB, Broude EV, Chang BD. If not apoptosis, then what? Treatment- induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat 2001, 4:303-313. 10.1054/drup.2001.0213, 11991684.
72. Lew DJ, Burke DJ. The spindle assembly and spindle position checkpoints. Annu Rev Genet 2003, 37:251-282. 10.1146/annurev.genet.37.042203.120656, 14616062.
73. Taylor SS, Scott MI, Holland AJ. The spindle checkpoint: a quality control mechanism which ensures accurate chromosome segregation. Chromosome Res 2004, 12:599-616. 10.1023/B:CHRO.0000036610.78380.51, 15289666.
74. Nurse P. Genetic control of cell size at cell division in yeast. Nature 1975, 256:547-551. 10.1038/256547a0, 1165770.
75. Paprskářová M, Kryštof V, Jorda R, Džubák P, Hajdúch M, We{ogonek}sierska JD, Strnad M. Functional p53 in cells contributes to the anticancer effect of the cyclin-dependent kinase inhibitor roscovitine. J Cell Biochem 2009, 3:428-437.
76. Padmakumar VC, Aleem E, Berthet C, Hilton MB, Kaldis P. Cdk2 and Cdk4 activities are dispensable for tumorigenesis caused by the loss of p53. Mol Cell Biol 2009, 29:2582-2593. 10.1128/MCB.00952-08, 2682046, 19307310.
77. Schmetsdorf S, Arnold E, Holzer M, Arendt T, Gärtner U. A putative role for cell cycle-related proteins in microtubule-basedneuroplasticity. Eur J Neurosci 2009, 29:1096-1107. 10.1111/j.1460-9568.2009.06661.x, 19302146.
78. Bailet O, Fenouille N, Abbe P, Robert G, Rocchi S, Gonthier N, Denoyelle C, Ticchioni M, Ortonne JP, Ballotti R, Deckert M, Tartare-Deckert S. Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest. Cancer Res 2009, 69:2748-2756. 10.1158/0008-5472.CAN-08-2690, 19293188.
79. Buchanan C, Stigliano I, Garay-Malpartida HM, Rodrigues Gomes L, Puricelli L, Sogayar MC, Bal de Kier Joffé E, Peters MG. Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways. Breast Cancer Res Treat 2010, 119(3):559-74. Epub 2009 Mar 14, 10.1007/s10549-009-0362-9, 19288189.
80. Whittaker SR, Te Poele RH, Chan F, Linardopoulos S, Walton MI, Garrett MD, Workman P. The cyclin-dependent kinase inhibitor seliciclib (R-roscovitine; CYC202) decreases the expression of mitotic control genes and prevents entry into mitosis. Cell Cycle 2007, 6:3114-3131.
81. Takagi K, Sowa Y, Cevik OM, Nakanishi R, Sakai T. CDK inhibitor enhances the sensitivity to 5-fluorouracil in colorectal cancer cells. Int J Oncol 2008, 32:1105-1110.
82. Bartek J, Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 2003, 3:421-429. 10.1016/S1535-6108(03)00110-7, 12781359.
83. Bencokova Z, Kaufmann MR, Pires IM, Lecane PS, Giaccia AJ, Hammond EM. ATM activation and signaling under hypoxic conditions. Mol Cell Biol 2009, 29:526-537. 10.1128/MCB.01301-08, 2612523, 18981219.
84. Cui B, Johnson SP, Bullock NH, Ali-Osman F, Bigner DD, Friedman HS. Bifunctional DNA Alkylator 1,3-bis(2-chloroethyl)-1-nitrosourea activates the ATR-Chk1 pathway independently of the mismatch repair pathway. Mol Pharmacol 2009, 6:1356-1363.
85. Warner SL, Stephens BJ, Von Hoff DD. Tubulin-associated proteins: Aurora and Polo-like kinases as therapeutic targets in cancer. Curr Oncol Rep 2008, 10:122-129. 10.1007/s11912-008-0020-0, 18377825.
86. Trenz K, Errico A, Costanzo V. Plx1 is required for chromosomal DNA replication under stressful conditions. EMBO J 2008, 27:876-885. 10.1038/emboj.2008.29, 2265110,2265110, 18309293.
87. Jiang N, Wang X, Jhanwar-Uniyal M, Darzynkiewicz Z, Dai W. Polo box domain of Plk3 functions as a centrosome localization signal, overexpression of which causes mitotic arrest, cytokinesis defects, and apoptosis. J Biol Chem 2006, 281(1):0577-10582.
88. Schmit TL, Ahmad N. Regulation of mitosis via mitotic kinases: new opportunities for cancer management. Mol Cancer Ther 2007, 7:1920-1931.
89. Lee KS, Yuan YL, Kuriyama R, Erikson RL. Plk is an M phase specific protein kinase and interacts with kinesin like protein, CHO/MKLP-1. Mol Cell Biol 1995, 15:7143-7151. 230970, 8524282.
90. Cude K, Wang Y, Choi HJ, Hsuan SL, Zhang H, Wang CY, Xia Z. Regulation of the G2-M cell cycle progression by the ERK5-NFkappaB signaling pathway. J Cell Biol 2007, 2:253-256.
91. Burkard ME, Randall CL, Larochelle S, Zhang C, Shokat KM, Fisher RP, Jallepalli PV. Chemical genetics reveals the requirement for Polo-like kinase 1 activity in positioning RhoA and triggering cytokinesis in human cells. Proc Natl Acad Sci USA 2007, 104:4383-4388. 10.1073/pnas.0701140104, 1838611, 17360533.
92. Mao HW, Liu WL, Zhou JF, Sun HY, Xu HZ, Luo XH. Expression of plk-1 gene in acute leukemia patients and its significance. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2006, 14:876-879.
93. Denkert C, Thoma A, Niesporek S, Weichert W, Koch I, Noske A, Schicktanz H, Burkhardt M, Jung K, Dietel M, Kristiansen G. Overexpression of cyclooxygenase-2 in human prostate carcinoma and prostatic intraepithelial neoplasia-association with increased expression of Polo-like kinase-1. Prostate 2007, 67:361-369. 10.1002/pros.20467, 17265445.
94. Kanaji S, Saito H, Tsujitani S, Matsumoto S, Tatebe S, Kondo A, Ozaki M, Ito H, Ikeguchi M. Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma. Oncology 2002, 70:126-133.
95. Syed N, Smith P, Sullivan A, Spender LC, Dyer M, Karran L, O'Nions J, Allday M, Hoffmann I, Crawford D, Griffin B, Farrell PJ, Crook T. Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies. Blood 2006, 107:250-256. 10.1182/blood-2005-03-1194, 16160013.
96. Kang T, Wei Y, Honaker Y, Yamaguchi H, Appella E, Hung MC, Piwnica-Worms H. GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. Cancer Cell 2003, 13:36-47.
97. Uckun FM. Chemosensitizing anti-cancer activity of LFM-A13, a leflunomide metabolite analog targeting polo-like kinases. Cell Cycle 2007, 6:3021-3026.
98. Uckun FM, Dibirdik I, Qazi S, Vassilev A, Ma H, Mao C, Benyumov A, Emami KH. Anti-breast cancer activity of LFM-A13, a potent inhibitor of Polo-like kinase (PLK). Bioorg Med Chem 2007, 15:800-814. 10.1016/j.bmc.2006.10.050, 17098432.
99. Carmena M, Earnshaw WC. The cellular geography of aurora kinases. Nat Rev Mol Cell Biol 2003, 4:842-854. 10.1038/nrm1245, 14625535.
100. Pinel S, Barbault-Foucher S, Lott-Desroches MC, Astier A. Inhibitors of aurora kinases. Ann Pharm Fr 2009, 67:69-77.
101. Anderson K, Lai Z, McDonald OB, Stuart JD, Nartey EN, Hardwicke MA, Newlander K, Dhanak D, Adams J, Patrick D, Copeland RA, Tummino PJ, Yang J. Biochemical characterization of GSK107 a potent and selective inhibitor of Aurora B and Aurora C Kinases with an extremely long residence time. Biochem J 0916, 2:259-265.
102. Dreier MR, Grabovich AZ, Katusin JD, Taylor WR. Short and long-term tumor cell responses to Aurora kinase inhibitors. Exp Cell Res 2009, 315:1085-1099. 10.1016/j.yexcr.2009.02.008, 19233169.
103. Parra MT, Gomez R, Viera A, Page J, Calvente A, Wordeman L, Rufas JS, Suja JA. A Perikinetochoric Ring Defined by MCAK and Aurora-B as a Novel Centromere Domain. PLoS Genet 2006, 2:e84. 10.1371/journal.pgen.0020084, 1472701,1472701, 16741559.
104. Tian WJ, Feng WL, Wang HB, Huang SF, Cao WX, Huang ZG. Inhibitory effect of wild-type p53 gene on excessive replication of centrosomes in leukemia cell line K562. Chin J Cancer 2009, 2:122-126.
105. Ferrand A, Chevrier V, Chauvin JP, Birnbaum D. Ajuba: a new microtubule-associated protein that interacts with BUBR1 and Aurora B at kinetochores in metaphase. Biol Cell 2009, 4:221-235.
106. Osmani AH, McGuire SL, Osmani SA. Parallel activation of NIMA and p34cdc2 cell cycle regulated protein kinases is required to initiate mitosis in A. nidulans. Cell 1991, 67:283-291. 10.1016/0092-8674(91)90180-7, 1913824.
107. Bowers AJ, Boylan JF. Nek8, a NIMA family kinase member, is over-expressed in primary human breast tumors. Gene 2004, 328:135-142. 10.1016/j.gene.2003.12.002, 15019993.
108. Chen Y, Chen PL, Chen CF, Jiang X, Riley DJ. Never-in-mitosis related kinase 1 functions in DNA damage response and checkpoint control. Cell Cycle 2008, 7:3194-3201. 2597191, 18843199.
109. Trapp ML, Galtseva A, Manning DK, Beier DR, Rosenblum ND, Quarmby LM. Defects in ciliary localization of Nek8 is associated with cystogenesis. Pediatr Nephrol 2008, 23:377-387. 10.1007/s00467-007-0692-y, 18189147.